Probiotic Lactobacillus casei Shirota improves kidney function, inflammation and bowel movements in hospitalized patients with acute gastroenteritis - A prospective study

Journal of Functional Foods

Volumn 17, Issue , 2015, Pages 305-313

  Akoglu, Bora ^a   Loytved, Alexander ^a   Nuiding, Hannah ^a   Zeuzem, Stefan ^b   Faust, Dominik ^c  

^a Praxis für Innere Medizin und Gastroenterologie   (Germany)

^b Asklepios Klinik Langen   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Acute gastroenteritis; Bowel movements; Inflammation; Kidney function; Lactobacillus casei Shirota; Probiotics

Indexed keywords

LACTOBACILLUS CASEI;

EID: 84938823053     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.05.021     Document Type: Article

References (35)

1. Aoki T., Asahara T., Matsumoto K., Takada T., Chonan O., Nakamori K., Nonaka C., Yamaji I., Hisamoto T., Sato M., Matsuda T., Nomoto K. Effects of the continuous intake of a milk drink containing Lactobacillus casei strain Shirota on abdominal symptoms, fecal microbiota, and metabolites in gastrectomized subjects. Scandinavian Journal of Gastroenterology 2014, 49(5):552-563.
2. Ashraf R., Vasiljevic T., Day S.L., Smith S.C., Donkor O.N. Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. Journal of Functional Foods 2014, 6:395-409.
3. Bartlett J.G., Chang T.W., Gurwith M., Gorbach S.L., Onderdonk A.B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. The New England Journal of Medicine 1978, 298(10):531-534.
4. Bohles N., Busch K., Hensel M. Vaccines against human diarrheal pathogens: Current status and perspectives. Human Vaccines & Immunotherapeutics 2014, 10(6).
5. Castellazzi A.M., Valsecchi C., Montagna L., Malfa P., Ciprandi G., Avanzini M.A., Marseglia G.L. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their mixture (PSMIX). Immunological Investigations 2007, 36(4):413-421.
6. de Vrese M., Marteau P.R. Probiotics and prebiotics: Effects on diarrhea. The Journal of Nutrition 2007, 137(3 Suppl. 2):803S-811S.
7. Di Bella S., Musso M., Cataldo M.A., Meledandri M., Bordi E., Capozzi D., Cava M.C., Chiaradonna P., Prignano G., Petrosillo N. Clostridium difficile infection in Italian urban hospitals. Data from 2006 through 2011. BMC Infectious Diseases 2013, 13(1):146.
8. Dong H., Rowland I., Thomas L.V., Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. European Journal of Nutrition 2013, 52(8):1853-1863.
9. Dong H., Rowland I., Tuohy K.M., Thomas L.V., Yaqoob P. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clinical and Experimental Immunology 2010, 161(2):378-388.
10. Eizaguirre I., Urkia N.G., Asensio A.B., Zubillaga I., Zubillaga P., Vidales C., Garcia-Arenzana J.M., Aldazabal P. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. Journal of Pediatric Surgery 2002, 37(5):699-702.
11. Gorbach S.L. Antibiotics and Clostridium difficile. The New England Journal of Medicine 1999, 341(22):1690-1691.
12. Gupta A., Khanna S. Community-acquired Clostridium difficile infection: An increasing public health threat. Infection and Drug Resistance 2014, 7:63-72.
13. Herrera M., Salva S., Villena J., Barbieri N., Alvarez S. Lactobacillus rhamnosus CRL1505 enhances systemic and respiratory innate immune response in immunocompromised malnourished mice. Journal of Functional Foods 2013, 5(4):1693-1704.
14. Hoover D.G., Rodriguez-Palacios A. Transmission of Clostridium difficile in foods. Infectious Disease Clinics of North America 2013, 27(3):675-685.
15. Hori T., Kiyoshima J., Shida K., Yasui H. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clinical and Diagnostic Laboratory Immunology 2001, 8(3):593-597.
16. Hori T., Kiyoshima J., Shida K., Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clinical and Diagnostic Laboratory Immunology 2002, 9(1):105-108.
17. Johnson S., Samore M.H., Farrow K.A., Killgore G.E., Tenover F.C., Lyras D., Rood J.I., DeGirolami P., Baltch A.L., Rafferty M.E., Pear S.M., Gerding D.N. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. The New England Journal of Medicine 1999, 341(22):1645-1651.
18. Kim J.-E., Chae C.S., Kim G.-C., Hwang W., Hwang J., Hwang S.-M., Kim Y., Ahn Y.-T., Park S.-G., Jun C.-D., Rudra D., Im S.-H. Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses. Journal of Functional Foods 2015, 13:350-362.
19. Krammer H.J., Seggern H., Schaumburg J., Neumer F. Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation. Coloproctology 2011, 33(2):109-113.
20. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2002, 34(3):346-353.
21. Lynen Jansen P., Stallmach A., Lohse A.W., Lerch M.M. [Development of gastrointestinal infectious diseases between 2000 and 2012]. Zeitschrift fur Gastroenterologie 2014, 52(6):549-557.
22. Magnusson M., Magnusson K.E., Sundqvist T., Denneberg T. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut 1991, 32(7):754-759.
23. Matsumoto K., Takada T., Shimizu K., Moriyama K., Kawakami K., Hirano K., Kajimoto O., Nomoto K. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. Journal of Bioscience and Bioengineering 2010, 110(5):547-552.
24. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. International Journal of Food Microbiology 1998, 41(2):133-140.
25. Mazlyn M.M., Nagarajah L.H., Fatimah A., Norimah A.K., Goh K.L. Effects of a probiotic fermented milk on functional constipation: A randomized, double-blind, placebo-controlled study. Journal of Gastroenterology and Hepatology 2013, 28(7):1141-1147.
26. Miranda Alatriste P.V., Urbina Arronte R., Gomez Espinosa C.O., Espinosa Cuevas Mde L. Effect of probiotics on human blood urea levels in patients with chronic renal failure. Nutricion Hospitalaria 2014, 29(3):582-590.
27. Nagao F., Nakayama M., Muto T., Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Bioscience, Biotechnology, and Biochemistry 2000, 64(12):2706-2708.
28. Nakabayashi I., Nakamura M., Kawakami K., Ohta T., Kato I., Uchida K., Yoshida M. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: A preliminary study. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2011, 26(3):1094-1098.
29. Patel S., Shukla R., Goyal A. Probiotics in valorization of innate immunity across various animal models. Journal of Functional Foods 2015, 14:549-561.
30. Power S.E., O'Toole P.W., Stanton C., Ross R.P., Fitzgerald G.F. Intestinal microbiota, diet and health. The British Journal of Nutrition 2014, 111(3):387-402.
31. Reale M., Boscolo P., Bellante V., Tarantelli C., Di Nicola M., Forcella L., Li Q., Morimoto K., Muraro R. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. The British Journal of Nutrition 2012, 108(2):308-314.
32. Sur D., Manna B., Niyogi S.K., Ramamurthy T., Palit A., Nomoto K., Takahashi T., Shima T., Tsuji H., Kurakawa T., Takeda Y., Nair G.B., Bhattacharya S.K. Role of probiotic in preventing acute diarrhoea in children: A community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiology and Infection 2011, 139(6):919-926.
33. Van Puyenbroeck K., Hens N., Coenen S., Michiels B., Beunckens C., Molenberghs G., Van Royen P., Verhoeven V. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: A randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. The American Journal of Clinical Nutrition 2012, 95(5):1165-1171.
34. Vaziri N.D., Wong J., Pahl M., Piceno Y.M., Yuan J., DeSantis T.Z., Ni Z., Nguyen T.H., Andersen G.L. Chronic kidney disease alters intestinal microbial flora. Kidney International 2013, 83(2):308-315.
35. Weiner H.L., da Cunha A.P., Quintana F., Wu H. Oral tolerance. Immunological Reviews 2011, 241(1):241-259.